Table 2.
AET Sample | SI Sample | |||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
0 Days (N = 49) | 1-2 Days (N = 44) | 3+ Days (N = 30) | P-Value | 0 Days (N = 72) | 1 Day (N = 23) | 2+ Days (N = 21) | P-Value | |
Age | 47.53 | 52.73 | 50.00 | .267 | 49.92 | 52.96 | 47.33 | .482 |
GerdQ | 8.71 | 9.43 | 10.40‡ | .038 | 8.76 | 9.78 | 10.90‡ | <.01 |
Total Symptoms† | 5.00 | 8.00‡ | 6.00 | .035 | 4.00 | 7.00‡ | 12.00‡ | <.01 |
EHAS Total | 29.35 | 33.68 | 31.33 | .311 | 29.08 | 35.30 | 33.38 | .118 |
Hypervigilance | 11.67 | 12.66 | 12.13 | .709 | 11.51 | 12.87 | 13.24 | .365 |
Anxiety | 17.67 | 21.02 | 18.97 | .183 | 17.57 | 22.43 | 20.14 | .057 |
Self-reported symptom frequency presented as median scores and analyzed using Kruskal Wallace Test
P < .05 compared to 0 Day positive AET/SI group